Please ensure Javascript is enabled for purposes of website accessibility

Parkinson’s Researchers Discover Disease Biomarker in Key Breakthrough

Parkinson's disease

An international group of researchers has discovered a new tool that can reveal a key pathology of Parkinson’s disease in brain and body cells.

The identification of the new biomarker, known as abnormal alpha-synuclein, opens a new chapter for research, according to The Michael J. Fox Foundation for Parkinson’s Research.

The foundation led the coalition and its landmark clinical study, Parkinson’s Progression Markers Initiative (PPMI).

Learn More:

Quick Contact